TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nixonnoxin AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
5,094
|
6,060
|
5,018 |
Financial expenses |
0
![]() |
0
|
4 |
Earnings before taxes |
3,204
|
5,569
|
3,589 |
EBITDA |
2,673
|
5,564
|
3,591 |
Total assets |
33,387
|
31,810
|
27,885 |
Current assets |
23,318
|
21,740
|
17,845 |
Current liabilities |
778
|
907
|
542 |
Equity capital |
30,952
|
29,348
|
25,961 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
92.7%
|
92.3%
|
93.1% |
Turnover per employee |
2,547
|
3,030
|
2,509 |
Profit as a percentage of turnover |
62.9%
|
91.9%
|
71.5% |
Return on assets (ROA) |
9.6%
|
17.5%
|
12.9% |
Current ratio |
2997.2%
|
2396.9%
|
3292.4% |
Return on equity (ROE) |
10.4%
|
19.0%
|
13.8% |
Change turnover |
-966
|
1,042
|
-1,796 |
Change turnover % |
-16%
|
21%
|
-26% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.